التفاصيل البيبلوغرافية
| العنوان: |
Prognostic implications of mitral valve geometry in patients with secondary mitral regurgitation: the COAPT trial. |
| المؤلفون: |
Namazi, Farnaz, Delgado, Victoria, Pio, Stephan Milhorini, Marsan, Nina Ajmone, Asch, Federico M, Medvedofsky, Diego, Weissman, Neil J, Zhou, Zhipeng, Redfors, Bjorn, Lindenfeld, JoAnn, Abraham, William T, Mack, Michael J, Stone, Gregg W, Bax, Jeroen J |
| المصدر: |
European Heart Journal - Cardiovascular Imaging; Nov2022, Vol. 23 Issue 11, p1540-1551, 12p |
| مصطلحات موضوعية: |
HEART failure treatment, MITRAL valve insufficiency, ECHOCARDIOGRAPHY, CAUSES of death, MEDICAL protocols, TREATMENT effectiveness, PROSTHETIC heart valves, HOSPITAL care, MITRAL valve, HEART failure, EVALUATION |
| مستخلص: |
Aims The impact of mitral valve geometry on outcomes after MitraClip treatment in secondary mitral regurgitation (MR) has not been examined. We therefore sought to evaluate the association between mitral valve geometry and outcomes of patients with heart failure (HF) and secondary MR treated with guideline-directed medical therapy (GDMT) and MitraClip. Methods and results Mitral valve geometry was assessed from the baseline echocardiograms in 614 patients from the COAPT trial. The primary endpoint for the present study was the composite of all-cause mortality or HF hospitalization (HFH) within 2 years. Effect of treatment arm (MitraClip plus maximally tolerated GDMT vs. GDMT alone) on outcomes according to baseline variables was assessed. Among 29 baseline mitral valve echocardiographic parameters, increasing anteroposterior mitral annular diameter was the only independent predictor of the composite endpoint of all-cause mortality or HFH [adjusted hazard ratio (aHR) per cm 1.49; P = 0.04]. The effective regurgitant orifice area (EROA) was independently associated with all-cause mortality alone (aHR per cm2 2.97; P = 0.04) but not with HFH, whereas increasing anteroposterior mitral annular diameter was independently associated with HFH alone (aHR per cm 1.85; P = 0.005) but not all-cause mortality. Other mitral valve morphologic parameters were unrelated to outcomes. MitraClip reduced HFH and mortality independent of anteroposterior mitral annular diameter and EROA (P interaction = 0.77 and 0.27, respectively). Conclusion In patients with HF and severe secondary MR, a large anteroposterior mitral annular diameter and greater EROA were the strongest echocardiographic predictors of HFH and death in patients treated with GDMT alone and with the MitraClip. [ABSTRACT FROM AUTHOR] |
|
Copyright of European Heart Journal - Cardiovascular Imaging is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder